▶ 調査レポート

眼科用医薬品の世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Drugs for Ophthalmology Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。眼科用医薬品の世界市場2020年:メーカー別、地域別、種類・用途別 / Global Drugs for Ophthalmology Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / MRC2012A3020資料のイメージです。• レポートコード:MRC2012A3020
• 出版社/出版日:GlobalInfoResearch / 2020年12月21日
• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:化学、材料
• 販売価格(消費税別)
  Single User¥393,240 (USD3,480)▷ お問い合わせ
  Multi User¥589,860 (USD5,220)▷ お問い合わせ
  Corporate User¥786,480 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、眼科用医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。眼科用医薬品の種類別市場規模(ジェル、アイソリューション、カプセル・錠剤、点眼薬、軟膏)、用途別市場規模(病院、小売薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Allergan、Regeneron、Valeant、Aerie Pharmaceuticals、Novartis、Pfizer、Santen Pharmaceutical、Genentech、Bayer、Takeda、
・地域別グローバル市場分析 2015年-2020年
・眼科用医薬品の北米市場(アメリカ、カナダ、メキシコ)
・眼科用医薬品のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・眼科用医薬品のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・眼科用医薬品の南米市場(ブラジル、アルゼンチン)
・眼科用医薬品の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ジェル、アイソリューション、カプセル・錠剤、点眼薬、軟膏
・用途別分析:病院、小売薬局
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Drugs for Ophthalmology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Drugs for Ophthalmology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Drugs for Ophthalmology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Drugs for Ophthalmology market has been segmented into
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments

By Application, Drugs for Ophthalmology has been segmented into:
Hospital
Retail Pharmacy

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Ophthalmology market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Ophthalmology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Ophthalmology market.

The report offers in-depth assessment of the growth and other aspects of the Drugs for Ophthalmology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Drugs for Ophthalmology Market Share Analysis
Drugs for Ophthalmology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Ophthalmology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Ophthalmology sales, revenue and market share for each player covered in this report.

The major players covered in Drugs for Ophthalmology are:
Allergan
Regeneron
Valeant
Aerie Pharmaceuticals
Novartis
Pfizer
Santen Pharmaceutical
Genentech
Bayer
Takeda

Among other players domestic and global, Drugs for Ophthalmology market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Ophthalmology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Ophthalmology, with price, sales, revenue and global market share of Drugs for Ophthalmology in 2018 and 2019.
Chapter 3, the Drugs for Ophthalmology competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Ophthalmology breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drugs for Ophthalmology market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drugs for Ophthalmology sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Drugs for Ophthalmology Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Ophthalmology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Gels
1.2.3 Eye Solutions
1.2.4 Capsules & Tablets
1.2.5 Eye Drops
1.2.6 Ointments
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Ophthalmology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Overview of Global Drugs for Ophthalmology Market
1.4.1 Global Drugs for Ophthalmology Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Regeneron
2.2.1 Regeneron Details
2.2.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Regeneron SWOT Analysis
2.2.4 Regeneron Product and Services
2.2.5 Regeneron Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Valeant
2.3.1 Valeant Details
2.3.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Valeant SWOT Analysis
2.3.4 Valeant Product and Services
2.3.5 Valeant Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Aerie Pharmaceuticals
2.4.1 Aerie Pharmaceuticals Details
2.4.2 Aerie Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aerie Pharmaceuticals SWOT Analysis
2.4.4 Aerie Pharmaceuticals Product and Services
2.4.5 Aerie Pharmaceuticals Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Santen Pharmaceutical
2.7.1 Santen Pharmaceutical Details
2.7.2 Santen Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Santen Pharmaceutical SWOT Analysis
2.7.4 Santen Pharmaceutical Product and Services
2.7.5 Santen Pharmaceutical Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genentech
2.8.1 Genentech Details
2.8.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genentech SWOT Analysis
2.8.4 Genentech Product and Services
2.8.5 Genentech Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer SWOT Analysis
2.9.4 Bayer Product and Services
2.9.5 Bayer Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda SWOT Analysis
2.10.4 Takeda Product and Services
2.10.5 Takeda Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drugs for Ophthalmology Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drugs for Ophthalmology Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Ophthalmology Manufacturer Market Share in 2019
3.3.2 Top 6 Drugs for Ophthalmology Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drugs for Ophthalmology Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Ophthalmology Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drugs for Ophthalmology Revenue and Market Share by Regions (2015-2020)
4.2 North America Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
4.3 Europe Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
4.5 South America Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drugs for Ophthalmology Sales, Revenue and Market Share by Country
5.1.1 North America Drugs for Ophthalmology Sales and Market Share by Country (2015-2020)
5.1.2 North America Drugs for Ophthalmology Revenue and Market Share by Country (2015-2020)
5.2 United States Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
5.3 Canada Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
5.4 Mexico Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drugs for Ophthalmology Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs for Ophthalmology Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drugs for Ophthalmology Revenue and Market Share by Country (2015-2020)
6.2 Germany Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
6.3 UK Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
6.4 France Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
6.5 Russia Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
6.6 Italy Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drugs for Ophthalmology Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drugs for Ophthalmology Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drugs for Ophthalmology Revenue and Market Share by Regions (2015-2020)
7.2 China Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
7.3 Japan Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
7.4 Korea Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
7.5 India Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
7.7 Australia Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drugs for Ophthalmology Sales, Revenue and Market Share by Country
8.1.1 South America Drugs for Ophthalmology Sales and Market Share by Country (2015-2020)
8.1.2 South America Drugs for Ophthalmology Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
8.3 Argentina Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Drugs for Ophthalmology Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Drugs for Ophthalmology Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Drugs for Ophthalmology Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
9.3 Turkey Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
9.4 Egypt Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
9.5 South Africa Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drugs for Ophthalmology Sales and Market Share by Type (2015-2020)
10.2 Global Drugs for Ophthalmology Revenue and Market Share by Type (2015-2020)
10.3 Global Drugs for Ophthalmology Price by Type (2015-2020)
11 Global Drugs for Ophthalmology Market Segment by Application
11.1 Global Drugs for Ophthalmology Sales Market Share by Application (2015-2020)
11.2 Global Drugs for Ophthalmology Revenue Market Share by Application (2015-2020)
11.3 Global Drugs for Ophthalmology Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drugs for Ophthalmology Sales, Revenue and Growth Rate (2021-2025)
12.2 Drugs for Ophthalmology Market Forecast by Regions (2021-2025)
12.2.1 North America Drugs for Ophthalmology Market Forecast (2021-2025)
12.2.2 Europe Drugs for Ophthalmology Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drugs for Ophthalmology Market Forecast (2021-2025)
12.2.4 South America Drugs for Ophthalmology Market Forecast (2021-2025)
12.2.5 Middle East & Africa Drugs for Ophthalmology Market Forecast (2021-2025)
12.3 Drugs for Ophthalmology Market Forecast by Type (2021-2025)
12.3.1 Global Drugs for Ophthalmology Sales Forecast by Type (2021-2025)
12.3.2 Global Drugs for Ophthalmology Market Share Forecast by Type (2021-2025)
12.4 Drugs for Ophthalmology Market Forecast by Application (2021-2025)
12.4.1 Global Drugs for Ophthalmology Sales Forecast by Application (2021-2025)
12.4.2 Global Drugs for Ophthalmology Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Drugs for Ophthalmology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Ophthalmology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Ophthalmology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Drugs for Ophthalmology Major Business
Table 9. Allergan Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 10. Allergan SWOT Analysis
Table 11. Allergan Drugs for Ophthalmology Product and Services
Table 12. Allergan Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Regeneron Basic Information, Manufacturing Base and Competitors
Table 14. Regeneron Drugs for Ophthalmology Major Business
Table 15. Regeneron Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 16. Regeneron SWOT Analysis
Table 17. Regeneron Drugs for Ophthalmology Product and Services
Table 18. Regeneron Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Valeant Basic Information, Manufacturing Base and Competitors
Table 20. Valeant Drugs for Ophthalmology Major Business
Table 21. Valeant Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 22. Valeant SWOT Analysis
Table 23. Valeant Drugs for Ophthalmology Product and Services
Table 24. Valeant Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Aerie Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 26. Aerie Pharmaceuticals Drugs for Ophthalmology Major Business
Table 27. Aerie Pharmaceuticals Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 28. Aerie Pharmaceuticals SWOT Analysis
Table 29. Aerie Pharmaceuticals Drugs for Ophthalmology Product and Services
Table 30. Aerie Pharmaceuticals Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Drugs for Ophthalmology Major Business
Table 33. Novartis Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 34. Novartis SWOT Analysis
Table 35. Novartis Drugs for Ophthalmology Product and Services
Table 36. Novartis Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Drugs for Ophthalmology Major Business
Table 39. Pfizer Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Drugs for Ophthalmology Product and Services
Table 42. Pfizer Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Santen Pharmaceutical Drugs for Ophthalmology Major Business
Table 45. Santen Pharmaceutical Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 46. Santen Pharmaceutical SWOT Analysis
Table 47. Santen Pharmaceutical Drugs for Ophthalmology Product and Services
Table 48. Santen Pharmaceutical Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Genentech Basic Information, Manufacturing Base and Competitors
Table 50. Genentech Drugs for Ophthalmology Major Business
Table 51. Genentech Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 52. Genentech SWOT Analysis
Table 53. Genentech Drugs for Ophthalmology Product and Services
Table 54. Genentech Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bayer Basic Information, Manufacturing Base and Competitors
Table 56. Bayer Drugs for Ophthalmology Major Business
Table 57. Bayer Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 58. Bayer SWOT Analysis
Table 59. Bayer Drugs for Ophthalmology Product and Services
Table 60. Bayer Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Drugs for Ophthalmology Major Business
Table 63. Takeda Drugs for Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 64. Takeda SWOT Analysis
Table 65. Takeda Drugs for Ophthalmology Product and Services
Table 66. Takeda Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Drugs for Ophthalmology Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Drugs for Ophthalmology Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Drugs for Ophthalmology Sales by Regions (2015-2020) (K Units)
Table 70. Global Drugs for Ophthalmology Sales Market Share by Regions (2015-2020)
Table 71. Global Drugs for Ophthalmology Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Drugs for Ophthalmology Sales by Countries (2015-2020) (K Units)
Table 73. North America Drugs for Ophthalmology Sales Market Share by Countries (2015-2020)
Table 74. North America Drugs for Ophthalmology Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Drugs for Ophthalmology Revenue Market Share by Countries (2015-2020)
Table 76. Europe Drugs for Ophthalmology Sales by Countries (2015-2020) (K Units)
Table 77. Europe Drugs for Ophthalmology Sales Market Share by Countries (2015-2020)
Table 78. Europe Drugs for Ophthalmology Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Drugs for Ophthalmology Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Drugs for Ophthalmology Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Drugs for Ophthalmology Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Drugs for Ophthalmology Sales by Countries (2015-2020) (K Units)
Table 83. South America Drugs for Ophthalmology Sales Market Share by Countries (2015-2020)
Table 84. South America Drugs for Ophthalmology Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Drugs for Ophthalmology Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Drugs for Ophthalmology Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Drugs for Ophthalmology Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Drugs for Ophthalmology Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Drugs for Ophthalmology Revenue Market Share by Countries (2015-2020)
Table 90. Global Drugs for Ophthalmology Sales by Type (2015-2020) (K Units)
Table 91. Global Drugs for Ophthalmology Sales Share by Type (2015-2020)
Table 92. Global Drugs for Ophthalmology Revenue by Type (2015-2020) (USD Million)
Table 93. Global Drugs for Ophthalmology Revenue Share by Type (2015-2020)
Table 94. Global Drugs for Ophthalmology Sales by Application (2015-2020) (K Units)
Table 95. Global Drugs for Ophthalmology Sales Share by Application (2015-2020)
Table 96. Global Drugs for Ophthalmology Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Drugs for Ophthalmology Market Share Forecast by Regions (2021-2025)
Table 98. Global Drugs for Ophthalmology Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Drugs for Ophthalmology Market Share Forecast by Type (2021-2025)
Table 100. Global Drugs for Ophthalmology Sales Forecast by Application (2021-2025)
Table 101. Global Drugs for Ophthalmology Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drugs for Ophthalmology Picture
Figure 2. Global Sales Market Share of Drugs for Ophthalmology by Type in 2019
Figure 3. Gels Picture
Figure 4. Eye Solutions Picture
Figure 5. Capsules & Tablets Picture
Figure 6. Eye Drops Picture
Figure 7. Ointments Picture
Figure 8. Drugs for Ophthalmology Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Global Drugs for Ophthalmology Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Drugs for Ophthalmology Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Drugs for Ophthalmology Sales Market Share by Manufacturer in 2019
Figure 32. Global Drugs for Ophthalmology Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Drugs for Ophthalmology Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Drugs for Ophthalmology Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Drugs for Ophthalmology Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Drugs for Ophthalmology Revenue Market Share by Regions (2015-2020)
Figure 39. Global Drugs for Ophthalmology Revenue Market Share by Regions in 2018
Figure 40. North America Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
Figure 41. Europe Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
Figure 43. South America Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Drugs for Ophthalmology Sales and Growth Rate (2015-2020)
Figure 45. North America Drugs for Ophthalmology Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Drugs for Ophthalmology Sales Market Share by Countries (2015-2020)
Figure 47. North America Drugs for Ophthalmology Sales Market Share by Countries in 2018
Figure 48. North America Drugs for Ophthalmology Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Drugs for Ophthalmology Revenue Market Share by Countries in 2018
Figure 50. United States Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Drugs for Ophthalmology Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Drugs for Ophthalmology Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Drugs for Ophthalmology Revenue Market Share by Countries in 2019
Figure 56. Germany Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Drugs for Ophthalmology Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Drugs for Ophthalmology Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Drugs for Ophthalmology Revenue Market Share by Regions 2019
Figure 64. China Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Drugs for Ophthalmology Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Drugs for Ophthalmology Sales Market Share by Countries in 2019
Figure 71. South America Drugs for Ophthalmology Revenue Market Share by Countries in 2019
Figure 72. Brazil Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Drugs for Ophthalmology Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Drugs for Ophthalmology Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Drugs for Ophthalmology Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Drugs for Ophthalmology Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Drugs for Ophthalmology Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Drugs for Ophthalmology Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Drugs for Ophthalmology Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Drugs for Ophthalmology Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Drugs for Ophthalmology Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Drugs for Ophthalmology Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Drugs for Ophthalmology Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Drugs for Ophthalmology Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel